Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers. - Stokes ME; Vasciaveo A; Small JC; Zask A; Reznik E; Smith N; Wang Q; Daniels J; Forouhar F; Rajbhandari P; Califano A; Stockwell BR (Cell chemical biology, 2024)